Clinical Trial

IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia

Name: IL-5 CAR-T Cell Therapy for Refractory/Relapsed Eosinophilic Leukemia — clinical trial record (NCT07257640)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is an open-label, single-arm clinical study designed to evaluate the efficacy and safety of IL-5 CAR-T cell therapy in the treatment of patients with CD125-positive eosinophilic leukemia.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-20.

Trial Details

NCT Number	NCT07257640
Lead Sponsor	Zhejiang University
Conditions	Hematologic Diseases, Neoplasms
Enrollment	20 participants
Start Date	2025-11-30
Primary Completion	2028-11-30 (estimated)
Study Completion	2028-11-30 (estimated)
Updated on ClinicalTrials.gov	2025-12-10